Boston, MA, September 12, 2016 -- WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials, today announced that Andrea Falkoff has been appointed Vice President of Operations. Having worked on imaging in clinical trials for more than 10 years, Ms. Falkoff adds to the company's extensive operational expertise in support of sponsors' clinical trials.
"We are happy that Ms. Falkoff has joined the WorldCare Clinical team. As we continue to strive to provide the highest quality of service in the imaging CRO industry, her breadth of knowledge, experience, and leadership are ideally-suited for helping sponsors achieve their goals," stated Aaron Timm, CEO of WorldCare Clinical.
Ms. Falkoff has more than 10 years of experience in clinical research, having managed imaging trials for pharmaceutical, biotechnology and medical device companies. She has a proven track record of ensuring high-quality, on-time service delivery to clients. Before joining WCC, Ms. Falkoff was Vice President of Imaging Operations at Intrinsic Imaging. Earlier in her career, Ms. Falkoff worked at Perceptive Informatics. She earned her Master's in Business Administration from Boston University.
About WorldCare Clinical
WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 60 countries. WCC's robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.
For more information on WCC's services, please visit our website at www.wcclinical.com or contact: